Results 161 to 170 of about 16,846 (200)

BRD9 at the crossroads of splicing, chromatin remodeling, and hematopoiesis. [PDF]

Proc Jpn Acad Ser B Phys Biol Sci
Yamasaki T, Nishimura K, Inoue D.
europepmc   +1 more source

Clinical Molecular Pathology and Treatment Developments in Advanced Uveal Melanoma: State of the Art. [PDF]

Oncol Res
Dore S, Sacchi M, Pinna A, Palmieri G, Paliogiannis P.   +4 more
europepmc   +1 more source

FIR/PUF60: Multifunctional Molecule Through RNA Splicing for Revealing the Novel Disease Mechanism and Effective Individualized Therapies. [PDF]

Int J Mol Sci
Matsushita K, Kitamura K, Tanaka N, Kobayashi S, Suenaga Y, Hoshino T.   +5 more
europepmc   +1 more source

Fbrsl1 is required for cranial neural crest development and reflects a conserved function of the human disease-associated protein.

Dis Model Mech
Gerstner S, Berger-Santangelo H, Kastens G, Scholtes T, Wäschenbach S, Pauli S, Borchers A.   +6 more
europepmc   +1 more source

Clinical and Biological Insights into Myelodysplastic Neoplasms Associated with Deletions of Chromosome 5q Region. [PDF]

Hematol Rep
Testa U, Castelli G, Pelosi E.
europepmc   +1 more source

Updates in low/intermediate-risk MDS. [PDF]

Hematology Am Soc Hematol Educ Program
Carraway HE.
europepmc   +1 more source

Novel agents and evolving strategies for anemia management in lower-risk myelodysplastic syndromes. [PDF]

Blood Res
Hong J.
europepmc   +1 more source

Reframing-renaming(?)-myelodysplastic syndromes/neoplasms and clonal hematopoiesis of indeterminate potential. [PDF]

Leukemia
Lee NC, Miao R, Young NS.
europepmc   +1 more source

Analysis of myeloid neoplasms with isolated trisomy 19 reveals a novel MDS subgroup characterized by the presence of ring sideroblasts, fibrosis and SRSF2 and/or ASXL1 mutations. [PDF]

J Hematop
Hebeda KM, Boudová L, Corsten MF, Ptáková N, Haferlach T, de Graaf AO, Cermak J, Vanecek T, Jansen JH, Stevens-Kroef MJPL, Kroeze LI.   +10 more
europepmc   +1 more source

Mutational Spectrum and Clinical Outcomes of Myelodysplastic/Myeloproliferative Neoplasms: A Single-Institution Study in Korea with Emphasis on <i>U2AF1</i>. [PDF]

J Clin Med
Park MS, Choi DH, Jang JH, Jung CW, Kim HJ, Kim HY.   +5 more
europepmc   +1 more source